Email Updates
Go to Basic Search
Results
Total Results: 2,359 records
Showing results for "terms".
-
effectivehealthcare.ahrq.gov/products/grant-manuscripts/cochrane-database-abstract
-
Final_multivariate_v22_CLEAN_03-11-2013 (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-binary-outcomes-evaluation_research.pdfMarch 11, 2013 - unreported outcomes are missing at random, the study’s contribution to the likelihood can be written in terms -
Cer-238-Cervical-Ripening-Appendix-E-1 (xls file)
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-1.xlsxJanuary 01, 2009 - Appendix E-1 Appendix E-1. Data Abstraction of Study Characteristics Table E-1-1 Table E-1-1. Study characteristics of RCTs addressing Key Questions 1 and 2 Key Question Author, Year Country Quality Rating Demographics and Baseline Characteristics Other Population Characteristics Reason fo… -
Ptsd-Adult-Treatment Executive (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_executive.pdfApril 01, 2013 - 1 Comparative Effectiveness Review Number 92 Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) Executive Summary Background Posttraumatic stress disorder (PTSD) is a mental disorder that may develop following exposure to a traumatic event. According to the 4t… -
effectivehealthcare.ahrq.gov/health-topics/memory/
-
effectivehealthcare.ahrq.gov/health-topics/quitting-smoking/
-
ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdfJanuary 01, 2023 - ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults Laurel A. Habel, Ph.D. William O. Cooper, M.D., M.P.H. Colin M. Sox, M.D. M.S. K. Arnold Chan, M.D., Sc.D. Patrick G. Arbogast, Ph.D. T. Craig Cheetham, Pharm.D., M.S. Virginia P. Quinn, Ph.D., M.P.H. Bruce H. Firema… -
Asthma-Immunotherapy-2010 Executive (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdfJanuary 01, 2010 - 1 Comparative Effectiveness Review Number 111 Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review Executive Summary Background Allergic rhinitis is a widespread clinical problem, estimated to affect 20 to 40 percent of the popu… -
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-adults_research.pdfNovember 01, 2011 - Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children and Youth Effective Health Care Program Number 35 Research Reports Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children and Youth William O. Cooper, M.…
-
Liver-Cancer Executive (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdfOctober 01, 2014 - 1 Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma Executive Summary Background and Objectives Hepatocellular carcinoma (HCC) is the most common primary malignant neoplasm of the liver, usually developing in individuals with chronic liver disease or cirrhosis. Worldwide, it is the f… -
Layout 1 (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdfJanuary 01, 2007 - Layout 1 Background Depressive disorders such as major depressive disorder (MDD), dysthymia, and subsyndromal depression (including minor depression) may be serious disabling illnesses. MDD is the most prevalent, affecting more than 16 percent (lifetime) of U.S. adults. In 2000, the U.S. economic burden of depressiv… -
Layout 1 (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdfOctober 01, 2010 - Layout 1 Background Cystic fibrosis (CF) is the second most common life-shortening, childhood-onset genetic disease in the United States, affecting approximately 30,000 people in the Nation. The gene responsible for CF encodes the cystic fibrosis transmembrane regulator (CFTR) protein, which regulates sodium and chl… -
effectivehealthcare.ahrq.gov/health-topics/assisted-living?page=1
-
effectivehealthcare.ahrq.gov/health-topics/assisted-living/
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/metanalysis-proportion-rate-comparison_research.pdfNovember 01, 2013 - proportions and rates, the discrete likelihood approaches performed better than the approximate methods in terms
-
effectivehealthcare.ahrq.gov/health-topics/coping-chronic-illnessAugust 26, 2020 - Strategies for Patient, Family, and Caregiver Engagement Technical Brief August 26, 2020
-
effectivehealthcare.ahrq.gov/health-topics/international-healthJune 24, 2013 - Global Health Evidence Evaluation Framework White Paper June 24, 2013
-
Cer-238-Cervical-Ripening-Appendix-E-2 (xls file)
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-2.xlsxJanuary 01, 2017 - Appendix E-2 Appendix E-2. Data Abstraction of Outcomes Table E-2-1 Table E-2-1. Outcomes from RCTs addressing Key Question 1 Author, Year Country Quality Rating Interventions Primary Effectiveness Outcomes Secondary Effectiveness Outcomes Primary Fetal Harms Outcomes Secondary Fetal Harms… -
#05 DEPRESSION (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdfJune 01, 2014 - #05 DEPRESSION AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 05: Depression and Other Mental Health Disorders Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD… -
effectivehealthcare.ahrq.gov/health-topics/lung-diseases?page=1
SHARE:
Search the AHRQ Archive
Information and reports more than 5 years old may be found in the AHRQ Archive site.
Search Within A Specific AHRQ Site
You selected to view results for the following site:
